Top Indian pharma stocks to buy: Here are BNP Paribas' picks
- Sharing its top stock picks, BNP Paribas said it continues to prefer Sun Pharma and Aurobindo Pharma
Global brokerage and research firm BNP Paribas projects its Indian pharma and healthcare coverage universe to report aggregate c6% year-on-year (YoY) revenue growth and c3% y-y earnings decline in 1QFY23.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more